2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance

Shih Chieh Chien, Po Sheng Chen, Yi Hsiang Huang, Sung Chun Tang, Yi Heng Li*, Hung I. Yeh

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations


Statin reduces low-density lipoprotein cholesterol and improves clinical outcomes in high risk patients. In general, statin is a safe and well-tolerated medication. However, varieties of adverse effects are reported in some patients and may interfere long-term drug compliance. Statin-associated muscle events and liver function change account for most of these adverse effects. Patients are regarded as statin intolerance if they need to discontinue statin therapy due to these adverse effects. To date, there is no universal standard definition of statin intolerance. But a pragmatic definition of statin intolerance is essential and helpful for clinicians in daily practice. In this article, after expert consensus meetings and literature review, criteria were recommended to identify patients with statin intolerance in Taiwan. The purpose of this statement is to help health care professionals in Taiwan to diagnose and manage individuals who develop muscular and hepatic side effects after statin therapy.

Original languageEnglish
Pages (from-to)1385-1392
Number of pages8
JournalJournal of the Formosan Medical Association
Issue number10
StatePublished - Oct 2019


  • Consensus
  • Side effect
  • Statin


Dive into the research topics of '2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance'. Together they form a unique fingerprint.

Cite this